Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes. [electronic resource]
- Haematologica May 2015
- 643-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1592-8721
10.3324/haematol.2014.118679 doi
Adult Aged Aged, 80 and over Case-Control Studies Cell Differentiation Cytotoxicity, Immunologic Female Humans Immunophenotyping Interleukin-2--pharmacology Killer Cells, Natural--cytology Lymphocyte Count Male Middle Aged Myelodysplastic Syndromes--diagnosis Phenotype Prognosis